RFI

MENU

Szukaj

    RFI

    Drop in a message and we will reach out to you

    A worker diligently fills out pharmacovigilance documentation, ensuring compliance with the EMA's Guideline on Good Pharmacovigilance Practices (GVP Module IV). This scene highlights the importance of risk-based audits for Marketing Authorisation Holders (MAH) to maintain a robust pharmacovigilance system.

    PhV

    The legislation on pharmacovigilance from July 2012 established legal requirements for the Marketing Authorisation Holder (MAH) to perform regular risk-based audits of its pharmacovigilance (PhV) system. The guidance on planning and conducting the legally required audits are included in the Guideline on Good Pharmacovigilance Practices (GVP Module IV) of the European Medicines Agency (EMA). Having adequately qualified and experienced auditors SciencePharma provides risk-based audit services to provide independent, objective opinion on the MAH pharmacovigilance system.

    See more

    How can we help You?

      Please be advised that the administrator of personal data entered in the above form is SciencePharma Sp. z o.o. with its registered office in Warsaw, Chełmska 30/34. These data are processed in order to receive incoming correspondence and respond to it. Providing personal data is voluntary, but necessary to send the form. Each person has the right to access their data and correct it.

      You can read the details on the protection of personal data here.